www.fdanews.com/articles/122427-provectus-data-for-pv-10-shows-markedly-longer-overall-survival

Provectus: Data for PV-10 Shows Markedly Longer Overall Survival

November 23, 2009

Provectus Pharmaceuticals, Inc. … announced that initial one year overall survival data from the first 20 subjects in the current Phase 2 trial showed comparable trends to Phase 1 survival data.
Genetic Engineering & Biotechnology News